COVID-19 Vaccines

With protesters in clear retreat, the end of the three-week protest against the country’s COVID-19 restrictions and the government appeared to be in sight.

Restaurant and venue owners largely praised Philadelphia’s decision to immediately end the requirement to present proof-of-vaccination to dine indoors.

City officials unveiled a four-level tier system to help them determine when certain COVID-19 mitigation efforts may be lifted.

The firefighters union says up to 30% of its members could be suspended under the mandate.

The FDA’s surprise announcement Friday set the expected schedule for vaccine eligibility for the youngest Americans back several months.

The FDA reversed course and said it had become clear it needed to wait for data on how well that third shot works for this age group.

The governor says people need to protect themselves with the mask mandate for businesses ending Friday, and for schools on April 1.

Citing recent data from the CDC, officials in the Garden State will use all of their outreach strategies to promote boosters.

The move could open the way for the very youngest Americans to start receiving shots by early March.

The FDA is pushing the company to submit its application based on the two-dose data for potential approval in February.

Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines.

The mandate is first taking effect first in jurisdictions that didn’t challenge the requirement in court.

The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.

COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.

City health officials announced earlier this year they had given out more than 260,000 booster doses since August. This is how the numbers break down.